Mesoblast Limited (ASX:MSB)
Australia
· Delayed Price · Currency is AUD 2.020
-0.130 (-6.05%)
Mar 28, 2025, 4:10 PM AEST
Mesoblast Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 5.67 | 5.9 | 7.5 | 10.21 | 7.43 | 32.16 | Upgrade
|
| Revenue Growth (YoY) | -24.07% | -21.32% | -26.54% | 37.35% | -76.88% | 92.30% | Upgrade
|
| Cost of Revenue | 26.66 | 41.07 | 54.92 | 63.57 | 85.73 | 81.5 | Upgrade
|
| Gross Profit | -20.99 | -35.17 | -47.42 | -53.36 | -78.3 | -49.34 | Upgrade
|
| Selling, General & Admin | 29.33 | 23.63 | 25.37 | 27.21 | 30.87 | 25.61 | Upgrade
|
| Research & Development | 0.93 | - | - | - | - | - | Upgrade
|
| Other Operating Expenses | 0.12 | -0.82 | -3.51 | 0 | -0.07 | -0.08 | Upgrade
|
| Operating Expenses | 30.38 | 22.8 | 21.87 | 27.21 | 30.8 | 25.53 | Upgrade
|
| Operating Income | -51.37 | -57.97 | -69.29 | -80.57 | -109.1 | -74.87 | Upgrade
|
| Interest Expense | -21.15 | -20.66 | -19.44 | -16.91 | -15.94 | -14.72 | Upgrade
|
| Interest & Investment Income | 1.82 | 1.82 | 0.83 | 0 | 0.02 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.87 | -0.08 | -0.16 | -0.54 | 1.47 | 0.25 | Upgrade
|
| Other Non Operating Income (Expenses) | -18 | -1.57 | -2.88 | 5.51 | 5.23 | 0.61 | Upgrade
|
| EBT Excluding Unusual Items | -89.57 | -78.45 | -90.95 | -92.5 | -118.32 | -88.74 | Upgrade
|
| Asset Writedown | - | - | 0.08 | - | - | - | Upgrade
|
| Other Unusual Items | -13.66 | -9.69 | 8.77 | 0.91 | 18.69 | 1.38 | Upgrade
|
| Pretax Income | -103.23 | -88.15 | -82.1 | -91.59 | -99.63 | -87.36 | Upgrade
|
| Income Tax Expense | 0.12 | -0.19 | -0.21 | -0.24 | -0.82 | -9.42 | Upgrade
|
| Net Income | -103.35 | -87.96 | -81.89 | -91.35 | -98.81 | -77.94 | Upgrade
|
| Net Income to Common | -103.35 | -87.96 | -81.89 | -91.35 | -98.81 | -77.94 | Upgrade
|
| Shares Outstanding (Basic) | 1,120 | 987 | 778 | 683 | 605 | 529 | Upgrade
|
| Shares Outstanding (Diluted) | 1,120 | 987 | 778 | 683 | 605 | 529 | Upgrade
|
| Shares Change (YoY) | 31.98% | 26.87% | 13.89% | 12.86% | 14.42% | 6.97% | Upgrade
|
| EPS (Basic) | -0.09 | -0.09 | -0.11 | -0.13 | -0.16 | -0.15 | Upgrade
|
| EPS (Diluted) | -0.09 | -0.09 | -0.11 | -0.13 | -0.16 | -0.15 | Upgrade
|
| Free Cash Flow | -42.72 | -48.73 | -63.53 | -65.94 | -102.4 | -58.46 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.05 | -0.08 | -0.10 | -0.17 | -0.11 | Upgrade
|
| Gross Margin | - | - | - | - | - | -153.44% | Upgrade
|
| Operating Margin | -906.03% | -982.24% | -923.73% | -789.09% | -1467.53% | -232.84% | Upgrade
|
| Profit Margin | -1822.77% | -1490.27% | -1091.71% | -894.59% | -1329.18% | -242.38% | Upgrade
|
| Free Cash Flow Margin | -753.51% | -825.63% | -846.99% | -645.76% | -1377.40% | -181.80% | Upgrade
|
| EBITDA | -49.43 | -56.08 | -66.84 | -77.91 | -106.52 | -72.71 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -226.13% | Upgrade
|
| D&A For EBITDA | 1.95 | 1.9 | 2.45 | 2.66 | 2.57 | 2.16 | Upgrade
|
| EBIT | -51.37 | -57.97 | -69.29 | -80.57 | -109.1 | -74.87 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -232.84% | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.